Christophe Douat
Chief Executive Officer bei MEDINCELL S.A.
Vermögen: 7 Mio $ am 31.03.2024
Aktive Positionen von Christophe Douat
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MEDINCELL S.A. | Chief Executive Officer | 09.01.2003 | - |
Founder | 09.01.2003 | - | |
Great North SARL | Chairman | - | - |
CM Biomaterials BV
CM Biomaterials BV Miscellaneous ManufacturingProducer Manufacturing CM Biomaterials BV is a Dutch company that manufactures plastic products. The joint venture company is based in Gorinchem, Netherlands. | Director/Board Member | - | - |
Karriereverlauf von Christophe Douat
Ehemalige bekannte Positionen von Christophe Douat
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
NANOBIOTIX | Director/Board Member | 28.06.2011 | 01.01.2017 |
Independent Dir/Board Member | 28.06.2011 | 01.01.2017 | |
Matignon Investissement et Gestion SAS
Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Private Equity Investor | 01.01.2001 | 01.05.2010 |
Matignon Technologies | Corporate Officer/Principal | 01.04.2001 | 01.04.2009 |
NANOBIOTIX | Director/Board Member | 01.01.2006 | 01.01.2009 |
Sabourin Lake Lodge | Corporate Officer/Principal | 01.01.1992 | 01.01.1997 |
Matignon Technologies II FCPR
Matignon Technologies II FCPR Investment ManagersFinance Matignon Technologies II FCPR invests in early to later-stage companies mostly located in France and the European Union. It focuses on companies in the medical field or in the information technology sectors with revenues below €50 million. It invests between €500,000 and €10 million from early stage to growth operations. | Founder | - | - |
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Ausbildung von Christophe Douat
University of Minnesota | Graduate Degree |
University of Calgary | Masters Business Admin |
École Nationale Supérieure des Mines de Paris | Undergraduate Degree |
Statistik
International
Frankreich | 9 |
Kanada | 3 |
Vereinigte Staaten | 2 |
Operativ
Director/Board Member | 5 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Consumer Services | 5 |
Finance | 3 |
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
NANOBIOTIX | Health Technology |
Private Unternehmen | 9 |
---|---|
Matignon Investissement et Gestion SAS
Matignon Investissement et Gestion SAS Investment ManagersFinance Matignon Investissement et Gestion SAS (MIG) is an independent management-owned private equity investment firm based in Paris. MIG was established in 1996 through a management buy-out of Acmer from Banque Worms, formerly part of AXA-UAP and acquired by Deutsche Bank AG in 2001. Following the acquisition, Acmer was delisted. MIG manages private equity and venture capital funds, both generalist and sector specific. | Finance |
Matignon Technologies II FCPR
Matignon Technologies II FCPR Investment ManagersFinance Matignon Technologies II FCPR invests in early to later-stage companies mostly located in France and the European Union. It focuses on companies in the medical field or in the information technology sectors with revenues below €50 million. It invests between €500,000 and €10 million from early stage to growth operations. | Finance |
Arterial Remodelling Technologies SA
Arterial Remodelling Technologies SA Pharmaceuticals: MajorHealth Technology Arterial Remodelling Technologies SA develops bioresorbable peripheral and coronary polymer stents. Its products includes ART PBS scaffold, procedure and Clinical data. The company was founded by Antoine Lafont, Michel Vert and J. Frederick Cornhill in 2001 and is headquartered in Paris, France. | Health Technology |
Groupement International d'Informatique de Santé SA
Groupement International d'Informatique de Santé SA Publishing: Books/MagazinesConsumer Services Groupement International d'Informatique de Santé SA engages in the management of an online health and nutrition portal. Its services include daily effectiveness index, weekly synthesis, dietitian consultation, LeDiet community, practical tools, and chef and LeDiet recipes. The company was founded on October 9, 1986 and is headquartered in Paris, France. | Consumer Services |
MedinCell SA | |
Great North SARL | |
CM Biomaterials BV
CM Biomaterials BV Miscellaneous ManufacturingProducer Manufacturing CM Biomaterials BV is a Dutch company that manufactures plastic products. The joint venture company is based in Gorinchem, Netherlands. | Producer Manufacturing |
Sabourin Lake Lodge | |
Matignon Technologies |
- Börse
- Insiders
- Christophe Douat
- Erfahrung